SCHEMBL17078758

SCHEMBL17078758

COC(=O)c1ccc(CN2C[C@@H](C)N(C(=O)Nc3ccccc3)[C@@H](C)C2)cc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ MAPT P10636 2/20 0.54
▸ FAAH O00519 6/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ GRIN2B Q13224 2/20 0.49
▸ GAA P10253 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ NAMPT P43490 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20420962 0.89 FAAH (0.51) MAPTFAAHNPC1RAB9APOLB
SCHEMBL17078581 0.87 MAPT (0.51) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17079016 0.86 CACNA1G (0.54) ALDH1A1MEN1KMT2AMAPT
SCHEMBL17078504 0.86 HDAC1 (0.57) ALDH1A1MAPTFAAHSMN1; SMN2RAB9A
SCHEMBL17078453 0.86 MEN1 (0.53) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL20432655 0.85 FAAH (0.65) MAPTFAAHSMN1; SMN2NPC1RAB9A
SCHEMBL17079040 0.85 KDM4E (0.51) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17078867 0.84 PTGDR2 (0.54) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17086785 0.83 HDAC1 (0.58) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17078776 0.83 HDAC1 (0.58) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2019-05-14 — — US disclosed
EP-3116859-B1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2018-08-01 — — EP disclosed
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-04-06 — — US disclosed
EP-3116859-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2017-01-18 — — EP disclosed
WO-2015137750-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same HDAC6, HDAC1, HDAC11 ALDH1A1 1133/4885MEN1 2537/4885KMT2A 43/4885
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME HDAC6, HDAC1, HDAC5 ALDH1A1 806/4885MEN1 3278/4885KMT2A 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback